← FDA Drug Approvals (Drugs@FDA)

AMPICILLIN SODIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HQ SPECLT PHARMA · Approved 1993-04-15

Drug application

FDA Application #

ANDA062772

Application type

Abbreviated New Drug Application (Generic)

Brand name

AMPICILLIN SODIUM

Generic name

AMPICILLIN

Active ingredients

AMPICILLIN SODIUM

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

HQ SPECLT PHARMA

Manufacturer

WG Critical Care, LLC

First approval

1993-04-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown